We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Metabolic Viral Host Properties

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: May 6, 2009
Last Update Posted: May 12, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hadassah Medical Organization
Patients' metabolic properties may affect their immune response. This study aims to assess the effect of hosts' metabolic properties to viral infection.

HCV Infection

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Hadassah Medical Organization:

Detailed Description:
Blood samples were drawn from patients with Gaucher disease and healthy individuals, with and without HCV. Blood samples were tested for protein specific T cell proliferation, IFNg and IL-10 using ELISPOT assays, serum IFNg, IL-2, IL-6, IL-10 and IL-4 levels. FACS analysis was used for evaluation of lymphocytes subsets.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Both male and female volunteers were recruited. with and without HCV infection, with and without Gaucher disease.

Inclusion Criteria:

  • inform consent

Exclusion Criteria:

  • at patients request
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Yaron Ilan, Hadassah medical organization
ClinicalTrials.gov Identifier: NCT00893308     History of Changes
Other Study ID Numbers: 481133- HMO-CTIL
First Submitted: April 26, 2009
First Posted: May 6, 2009
Last Update Posted: May 12, 2009
Last Verified: May 2009